Panida Sriaroon
Pediatric Allergy/Immunology · Saint Petersburg, FLNPI 1891994208
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $48,224 of the $70,294 with a category attached, or 68.6%. 15 manufacturers reported payments, led by Genentech USA, Inc. at 37.5% of the total. Reporting peaked in 2022 at $21,493 and has fallen 57.2% since, to $9,197 in 2025.
Across 82 payments — averaging $857.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$26K
- Aimmune Therapeutics, Inc.$21K
- CSL Behring$8K
- Genentech, Inc.$4K
- Greer Laboratories, Inc.$4K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- plus $5K from 9 others
Across 114 payments — averaging $2528.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$213K
- Novartis$30K
- Alk-abello, Inc$20K
- F. Hoffmann-la Roche AG$14K
- CSL Behring$11K
What the payments were for
- Consulting fees$12,31118%
- Speaking & faculty fees$48,22469%
- Travel & lodging$7,03710%
- Food & beverage$2,6284%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 28 | $26,373 |
| Aimmune Therapeutics, Inc. | 12 | $20,693 |
| CSL Behring | 15 | $7,750 |
| Genentech, Inc. | 6 | $4,022 |
| Greer Laboratories, Inc. | 1 | $3,600 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $3,021 |
| Alk-abello, Inc | 4 | $2,525 |
| Sanofi | 2 | $1,170 |
| GSK | 1 | $325 |
| Novartis | 3 | $324 |
| Shire North American Group Inc | 1 | $121 |
| Phadia US Inc. | 2 | $109 |
| AstraZeneca | 1 | $105 |
| Regeneron Healthcare Solutions, Inc. | 1 | $95 |
| E.r. Squibb & Sons, L.L.C. | 1 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$70,294 in reported general payments places this provider in the 85th percentile of 30 pediatric allergy/immunology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $67,764 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $7,750 | $67,76413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 30 pediatric allergy/immunology providers in Florida.
Other pediatric allergy/immunology in Saint Petersburg
- Bhumika PatelSaint Petersburg$4K
- Mark BallowTampa$324K
- Vivian Hernandez-TrujilloMiami Lakes$285K
- Jolan WalterSt Petersburg$232K
- Jennifer LeidingOrlando$214K
- Hary KatzJacksonville$67K
- Jonathan MalkaNorth Miami Beach$32K
- Johana Castro WagnerLargo$15K
- Diana MartinTampa$12K
- Sharon LeonardJacksonville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.